The pathogenesis of THRLBCL involves several genetic alterations also seen in DLBCL, including overexpression of BCL2 and mutations in TNFAIP3 and MYD88 (L265P), which promote tumor cell survival. This evidence concerns the gene TNFAIP3 and diffuse large B-cell lymphoma.